Gene · 3399
Papers2,841
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 2,841
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Subcellular location of source proteins improves prediction of neoantigens for immunotherapy. | EMBO J | 2022 | 36314681 | PubTator, text mining | PubMed |
| CXCR5+CD8 T cells: Potential immunotherapy targets or drivers of immune-mediated adverse events? | Front Med (Lausanne) | 2022 | 36314014 | PubTator, text mining | PubMed |
| Regulation of Molecular Targets in Osteosarcoma Treatment. | Int J Mol Sci | 2022 | 36293439 | PubTator, text mining | PubMed |
| Recent Advancements in Molecular Therapeutics for Corneal Scar Treatment. | Cells | 2022 | 36291182 | PubTator, text mining | PubMed |
| Prospective approaches to enhancing CAR T cell therapy for glioblastoma. | Front Immunol | 2022 | 36275671 | PubTator, text mining | PubMed |
| Delineating the transcriptional landscape and clonal diversity of virus-specific CD4+ T cells during chronic viral infection. | Elife | 2022 | 36255051 | PubTator, text mining | PubMed |
| Impaired TIGIT expression on B cells drives circulating follicular helper T cell expansion in multiple sclerosis. | J Clin Invest | 2022 | 36250467 | PubTator, text mining | PubMed |
| Whole-exome sequencing analysis identifies distinct mutational profile and novel prognostic biomarkers in primary gastrointestinal diffuse large B-cell lymphoma. | Exp Hematol Oncol | 2022 | 36243813 | PubTator, text mining | PubMed |
| Identification of differentially expressed genes induced by aberrant methylation in acute myeloid leukemia using integrated bioinformatics analyses. | Oncol Lett | 2022 | 36238356 | PubTator, text mining | PubMed |
| ALDH3A2, ODF2, QSOX2, and MicroRNA-503-5p Expression to Forecast Recurrence in TMPRSS2-ERG-Positive Prostate Cancer. | Int J Mol Sci | 2022 | 36232996 | PubTator, text mining | PubMed |
Comprehensive Genomic Profiling (CGP)-Informed Personalized Molecular Residual Disease (MRD) Detection: An Exploratory Analysis from the PREDATOR Study of Metastatic Colorectal Cancer (mCRC) Patients Undergoing Surgical Resection. | Int J Mol Sci | 2022 | 36232827 | PubTator, text mining | PubMed |
| What Do the Transcriptome and Proteome of Menstrual Blood-Derived Mesenchymal Stem Cells Tell Us about Endometriosis? | Int J Mol Sci | 2022 | 36232817 | PubTator, text mining | PubMed |
| Richter Syndrome: From Molecular Pathogenesis to Druggable Targets. | Cancers (Basel) | 2022 | 36230566 | PubTator, text mining | PubMed |
| Machine learning predicts the prognosis of breast cancer patients with initial bone metastases. | Front Public Health | 2022 | 36225783 | PubTator, text mining | PubMed |
| NLRP3 Inflammasome Simultaneously Involved in Autophagy and Phagocytosis of THP-1 Cells to Clear Aged Erythrocytes. | J Immunol Res | 2022 | 36213328 | PubTator, text mining | PubMed |
| Bioinformatics and systems-biology analysis to determine the effects of Coronavirus disease 2019 on patients with allergic asthma. | Front Immunol | 2022 | 36211429 | PubTator, text mining | PubMed |
| Evaluating a tool to improve engagement and recruitment of under-served groups in trials. | Trials | 2022 | 36210444 | PubTator, text mining | PubMed |
| Application of synthetic biology in bladder cancer. | Chin Med J (Engl) | 2022 | 36209735 | PubTator, text mining | PubMed |
| A MYC-ZNF148-ID1/3 regulatory axis modulating cancer stem cell traits in aggressive breast cancer. | Oncogenesis | 2022 | 36207293 | PubTator, text mining | PubMed |
| Living with primary brain calcification with PDGFB variants: A qualitative study. | PLoS One | 2022 | 36206226 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3399/papers?page=27